The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China

Vaccine

Volumn 30, Issue 49, 2012, Pages 7118-7122

  Li, Fan ^a   Wang, Qixia ^b   Zhang, Lei ^a   Su, Haixia ^a   Zhang, Jingxia ^a   Wang, Tingcai ^c   Huang, Dahong ^c   Wu, Jun ^d   Yan, Yongping ^a   Fan, Daiming ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Wuwei Municipal Center for Disease Control and Prevention   (China)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Chronic hepatitis B; Hepatitis B immunoglobulin; Hepatitis B vaccine; Hepatitis B virus; Mother to child transmission

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DISEASE CARRIER; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; UNIVARIATE ANALYSIS;

ADULT; CHILD, PRESCHOOL; CHINA; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84869092884     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.031     Document Type: Article

References (32)

1. Chang M.H., Chen T.H.H., Hsu H.M., Wu T.C., Kong M.S., Liang D.C., et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 2005, 11:7953-7957.
2. Zeng G., Wang Z., Wen S., Jiang J., Wang L., Cheng J., et al. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 2005, 12:609-617.
3. Zanetti A.R., Van Damme P., Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008, 26:6266-6273.
4. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005, 34:S1-S3.
5. Wang Z., Huang Y., Wen S., Zhou B., Hou J. Hepatitis B virus genotypes and subgenotypes in China. Hepatol Res 2007, 37:S36-S41.
6. Liaw Y.F., Chu C.M. Hepatitis B virus infection. The Lancet 2009, 373:582-592.
7. Chang M.H. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007, 12:160-167.
8. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34:1329-1339.
9. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27:6550-6557.
10. Xiao X.M., Li A.Z., Chen X., Zhu Y.K., Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynecol Obstet 2007, 96:167-170.
11. Young B., Lee S.S., Lim W.L., Yeoh E.K. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat 2003, 10:23-30.
12. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, Wiley-Interscience Publication, New York.
13. The reported incidence rate of Hepatitis B in China. Website of Chinese CDC. [accessed 15.11.11]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html.
14. Wiseman E., Fraser M.A., Holden S., Glass A., Kidson B.L., Heron L.G., et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009, 190:489-492.
15. Del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997, 15:1624-1630.
16. Soleimani Amiri M.J., Hasanjani Roushan M.R., Baiany M., Taheri H., Hasanjani Roushan M. Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran. J Clin Virol 2010, 49:283-285.
17. Zhang L., Zhang W., Zhai X.J., Li Y.P., Li J., Yan B.Y., et al. Comparison of primary antibody immune response 5μg and 10μg of recombinant hepatitis B vaccine in newborn infants. Chin J Epidemiol 2012, 33:305-308.
18. Bzowej N.H. Hepatitis B therapy in pregnancy. Curr Hepat Rep 2010, 1-8.
19. Shao Z.J., Zhang L., Xu J.Q., Xu D.Z., Men K., Zhang J.X., et al. Mother-to-infant transmission of hepatitis B virus: a chinese experience. J Med Virol 2011, 83:791-795.
20. Wang Z., Zhang J., Yang H., Li X., Wen S., Guo Y., et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003, 71:360-366.
21. Hou J., Liu Z., Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005, 2:50-57.
22. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006, 332:328-336.
23. Pan C.Q., Duan Z., Bhamidimarri K.R., Zou H., Liang X., Li J., et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2011.
24. Warszawski J., Tubiana R., Le Chenadec J., Blanche S., Teglas J.P., Dollfus C., et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008, 22:289-299.
25. Townsend C.L., Cortina-Borja M., Peckham C.S., Tookey P.A. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007, 21:1019-1026.
26. Shao Z.J., Xu D.Z., Xu J.Q., Li J.H., Yan Y.P., Men K., et al. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: a prospective case-control study. J Gastroen Hepatol 2007, 22:165-170.
27. Liao M.T., Chang M.H., Lin F.G., Tsai I.J., Chang Y.W., Tsau Y.K. Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 2011, 128:e600-e604.
28. Ranger-Rogez S., Denis F. Hepatitis B mother-to-child transmission. Expert Rev Anti-infect Ther 2004, 2:133-145.
29. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007, 166:813-818.
30. Xu D.Z., Yan Y.P., Choi B.C.K., Xu J.Q., Men K., Zhang J.X., et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002, 67:20-26.
31. Lu F.M., Zhuang H. Management of hepatitis B in China. Chin Med J (Engl) 2009, 122:3-4.
32. Mast E.E., Weinbaum C.M., Fiore A.E., Alter M.J., Bell B.P., Finelli L., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: Immunization of adults. MMWR Recomm Rep 2006, 55(RR-16):1-33.